Skip to content
OSRHOSR Health, Inc.

Earnings

When OSR Health, Inc. reports, what it reported each quarter, and how the stock took the results.

19 quarters. Mar 31, 2022 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

10-K due Mar 29 – Apr 23

No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 4 filings.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 29 – Apr 23

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$381.27K
Revenue, change from a year earlier: Q3 2026 −16.4%, Q2 2026 −72.2%, Q1 2026 −36.4%, Q4 2025 −58.3%
Net income
-$8.31M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q1 2026 n/m, Q1 2025 n/m, Q3 2024 n/m, Q2 2024 n/m

Quarter by quarter

Q3 2026$524.79K−16.4% vs Q3 2025

Latest results

  1. Q3 2026Nov 13, 2026, before the open
    Revenue
    $524.79K
    −16.4%
    Net income
    -$1.61M
    N/M
    EPS
    —
    —
  2. Q2 2026Aug 14, 2026, during market hours+8.4%by the close of Aug 14
    Revenue
    $315.67K
    −72.2%
    Net income
    -$1.00M
    N/M
    EPS
    —
    —
  3. Q1 2026May 13, 2026, before the open3.9%by the close of May 13
    Revenue
    $484.06K
    −36.4%
    Net income
    -$3.47M
    N/M
    EPS
    -$0.08
    N/M
  4. Q4 2025Mar 31, 2026, after the close3.7%by the close of Apr 1
    Revenue
    $381.27K
    −58.3%
    Net income
    -$8.31M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026—Nov 13, 202644 d10-Q$524.79K−16.4%——
Q2 2026Jun 30, 2026—Aug 14, 202645 d10-Q$315.67K−72.2%—+8.4%
Q1 2026Mar 31, 2026—May 13, 202643 d10-Q$484.06K−36.4%-$0.083.9%
FY 2025
Q4 2025derivedDec 31, 2025—Mar 31, 202690 d10-K$381.27K−58.3%—3.7%
Q3 2025Sep 30, 2025—Nov 12, 202543 d10-Q$627.75K−23.7%—+6.2%
Q2 2025Jun 30, 2025—Aug 14, 202545 d10-Q$1.14M+28.8%—1.4%
Q1 2025Mar 31, 2025—May 20, 202550 d10-Q$761.27K−16.4%-$1.04+3.5%
FY 2024
Q4 2024derivedDec 31, 2024—Apr 22, 2025112 d10-K$915.25K——+3.8%
Q3 2024Sep 30, 2024—Nov 14, 202445 d10-Q$823.00K—-$0.06—
Q2 2024Jun 30, 2024—Aug 19, 202450 d10-Q$881.83K—-$0.02—
Q1 2024Mar 31, 2024—May 15, 202445 d10-Q$910.23K—-$0.01—
Earlier years, FY 2022 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 13, 2026000013
10-QAug 14, 2026089904
10-QMay 13, 2026055492
10-KMar 31, 2026037395
10-QNov 12, 2025109054
10-QAug 14, 2025076461
10-QMay 20, 2025045947
10-KApr 22, 2025034116
10-QNov 14, 2024258772
10-QAug 19, 2024202828

Provenance

ProvenanceData status and checks

OSR Health, Inc. · CIK 1840425 · Engraved from SEC EDGAR